Yohei Ohno

PCRonline @ ACC.26 Scientific Sessions

12 Mar 2026

Live updates on a selection of major Late Breaking Clinical Trials of interest in interventional cardiology presented at the American College of Cardiology 2026 Scientific Sessions #ACC26

Coronary access and revascularisation in patients undergoing TAVI: from work-up to lifetime management

15 Feb 2026 – From PCR Tokyo Valves 2026

This session delves into the comprehensive management of ischemic heart disease in patients undergoing transcatheter aortic valve implantation (TAVI). It highlights the critical importance of maintaining coronary access post-TAVI and explores how various valve designs affect coronary accessibility, particularly in cases involving valve-in-valve (TAV-in-TAV) procedures, guiding...

Coronary access and revascularisation in patients undergoing TAVI: from work-up to lifetime management

PCR Tokyo Valves 2026 Closing Ceremony

15 Feb 2026 – From PCR Tokyo Valves 2026

The Closing Ceremony marks the conclusion of this cardiology conference, providing a formal wrap-up and reflection on the key highlights and advancements presented throughout the event. It serves as an opportunity to acknowledge contributors and set the stage for future initiatives in interventional cardiology.

From diagnosis to device: decision-making and planning for mitral valve interventions

15 Feb 2026 – From PCR Tokyo Valves 2026

This session offers a structured approach to mitral TEER, integrating advanced imaging techniques for detailed mitral valve morphology evaluation, procedural planning, and complication prediction. It highlights device selection considerations and emerging technologies to tailor interventions for complex mitral valve disease, supported by multiple case presentations and...

From diagnosis to device: decision-making and planning for mitral valve interventions

Future devices and techniques for structural heart disease

15 Feb 2026 – From PCR Tokyo Valves 2026

This session surveys the future landscape of structural heart disease treatment, addressing current limitations in transcatheter valve technologies and presenting emerging devices and techniques for aortic, mitral, and tricuspid valves. Attendees will gain insights into innovations poised to transform therapeutic options for structural heart disease.

Future devices and techniques for structural heart disease

Mitral and aortic transcatheter valve-in-valve intervention - LIVE case

14 Feb 2026 – From PCR Tokyo Valves 2026

Live case
An 83-year-old male with AF, CKD (stage 3A), preserved LV function, and a history of AVR (27 mm Magna Ease) and MVR (33 mm Magna) in 2014 presented with symptomatic stenosis of the mitral bioprosthesis. A Sapien 3 valve was implanted in the Magna mitral...

Mitral and aortic transcatheter valve-in-valve intervention - LIVE case

Learn from the experts: lifetime management for Evolut first redo TAVI (TAV-in-TAV) and explant

14 Feb 2026 – From PCR Tokyo Valves 2026

This session offers an in-depth exploration of lifetime management strategies for patients undergoing Evolut first redo TAVI procedures, including TAV-in-TAV and explant techniques. It provides a comprehensive understanding of clinical decision-making algorithms, technical challenges, and key considerations for successful procedural planning and execution, supported by real-world...

Learn from the experts: lifetime management for Evolut first redo TAVI (TAV-in-TAV) and explant

PCR Tokyo Valves 2026 Welcome Ceremony

14 Feb 2026 – From PCR Tokyo Valves 2026

The Welcome Ceremony marks the commencement of the conference, setting the stage for an engaging and informative program dedicated to advances in cardiology and interventional techniques. It provides attendees with an overview of the event's objectives and highlights the collaborative spirit of the cardiology community.

Protect the brain for TAVI - True potential of SENTINEL Cerebral Protection System

14 Feb 2026 – From PCR Tokyo Valves 2026

This session highlights the critical role of cerebral protection during TAVI procedures by focusing on the SENTINEL Cerebral Protection System. It reviews trends in the United States and Japan, presents clinical outcomes one year post-introduction in Japan, and examines key clinical trials through a meta-analysis comparing...

Protect the brain for TAVI - True potential of SENTINEL Cerebral Protection System

Mastering techniques from basic to complex - Mitral regurgitation assessment and suitability for TEER

13 Feb 2026 – From PCR Tokyo Valves 2026

Delve into the assessment of mitral regurgitation and the criteria determining suitability for Transcatheter Edge-to-Edge Repair (TEER). This session reviews mitral valve anatomy and the latest clinical data supporting mitral TEER interventions.

Mastering techniques from basic to complex - Mitral regurgitation assessment and suitability for TEER

Mastering techniques from basic to complex - Tricuspid TEER fundamentals

13 Feb 2026 – From PCR Tokyo Valves 2026

Gain foundational knowledge in tricuspid TEER by understanding anatomical criteria for patient suitability, key procedural steps, and device techniques, enhanced by simulation-based procedural training.

Mastering techniques from basic to complex - Tricuspid TEER fundamentals

Design that delivers the future of TAVI

13 Feb 2026 – From PCR Tokyo Valves 2026

This session presents the future of TAVI valve design, emphasizing supra-annular valve benefits, strategies for managing concomitant coronary artery disease, and redo-TAVI approaches tailored for long-term patient management.

Featured research - TAVI - Part 12

18 Nov 2025 – From PCR London Valves 2025

This session presents advanced research on transcatheter aortic valve implantation (TAVI), featuring an extensive 30-year in-vitro durability analysis of the Evolut self-expanding valve. It also covers predictive studies on valve-in-valve procedure volumes comparing Japan and the United States, insights into TAVI in patients with left ventricular...

Complex valve-in-valve leaflet modification - LIVE Case

17 Nov 2025 – From PCR London Valves 2025

Watch this LIVE case followed by a recorded case, regarding a 79-year-old male with permanent AF and a history of surgical aortic valve replacement in 2010 (Magna Ease 25) who presented with symptomatic bioprosthetic valve stenosis, normal LV function, and no CAD. A Sapien 3 Ultra...

Complex valve-in-valve leaflet modification - LIVE Case

Mastering mitral and tricuspid TEER: clinical strategies in patients with complex anatomy

17 Nov 2025 – From PCR London Valves 2025

Find out more about advanced mitral and tricuspid TEER techniques for patients with challenging anatomy. This PCR London Valves 2025 session highlights real-world approaches from the Asia Pacific region, including consensus recommendations from the Asian Pacific Society of Cardiology, strategies for simultaneous mitral TEER and left...

Mastering mitral and tricuspid TEER: clinical strategies in patients with complex anatomy

How to optimise TAVI outcomes in extreme patient anatomies?

16 Nov 2025 – From PCR London Valves 2025

Explore strategies to optimise TAVI outcomes in patients with extreme anatomies in this PCR London Valves 2025 session.

Through case-based discussions, the session addresses challenges in small annular anatomy, approaches for large annuli, and strategies to ensure optimal lifetime management for younger TAVI patients. Learn practical tips...

How to optimise TAVI outcomes in extreme patient anatomies?

PCR @ TCT 2025 - Get the international perspective!

15 Oct 2025

Thanks to the contribution of a team of interventional cardiologists from around the globe, get the international perspective on Late-breaking Clinical Trials and Science released at TCT 2025 - check out the list below.

DOUBLE-CHOICE: Anesthesia strategies and self-expanding valve types for TAVI

29 Aug 2025

Fresh from his DOUBLE-CHOICE trial presentation at ESC Congress 2025 in Madrid, Mohamed Abdel-Wahab joins Yohei Ohno to discuss the key takeaways.

This two-by-two factorial randomised trial in patients undergoing TAVI compared a minimalist strategy using only local anesthesia with the standard of care, as well as two...

Author

Yohei Ohno

Author

Mohamed Abdel-Wahab

PCRonline @ ESC Congress 2025: the interventional cardiology perspective!

26 Jul 2025

Stay updated with the latest in interventional cardiology at #ESCCongress 2025!

TAVI outcomes

22 May 2025 – From EuroPCR 2025

Examine contemporary outcomes of transcatheter aortic valve implantation (TAVI) across diverse patient populations and device generations. This session presents data on severe aortic stenosis stratified by resting gradient, comparisons between bicuspid and tricuspid valve stenosis, and clinical results of intra-annular versus supra-annular devices, including two-year outcomes...

How to optimise TAVI outcomes in the Asian-Pacific population?

22 May 2025 – From EuroPCR 2025

What are the key considerations for TAVI in Asian-Pacific patients? This EuroPCR 2025 session focuses on optimising outcomes in anatomically and clinically specific contexts, such as patients with small annuli. Learn how the latest intra-annular self-expanding devices can help reduce post-procedural pacemaker implantation (PPI) rates, and...

How to optimise TAVI outcomes in the Asian-Pacific population?

5-year outcomes after transcatheter or surgical aortic valve replacement in low-risk patients with aortic stenosis (Evolut Low Risk)

01 Apr 2025

Yohei Ohno provides his takeaways from the results of the Evolut Low Risk trial which was presented by Michael J. Reardon during the ACC.25 in Chicago.

Author

Yohei Ohno